News und Analysen
Verizon, Walgreens, 3M: 3 high-yield Dow stocks to buy now?
Verizon Communications Inc. (NYSE: VZ), Walgreens Boots Alliance Inc. (NASDAQ: WBA) and 3M (NYSE: MMM) are among the highest-yielding components of the Dow Jones Industrial Average.
Are these
Clorox cleans up after post-COVID normalization and a cyberattack
The Clorox Co. (NYSE: CLX) is a household name, especially after the pandemic. The name is synonymous with disinfectants and cleaning products. Clorox is a member of the consumer staples sector
PayPal stock making a sudden turn, earnings breakout?
The market is currently at a tipping point, whether investors at large want to admit it or not. With the major indices trading at all-time highs, most market participants tend to fall into a
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren begeistert. Neuer 312% Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 312% mit Biotech Aktientip
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren begeistert. 312% Biotech Aktientip nach 15973% BioNTech
05.02.24 08:02
London (www.aktiencheck.de , Anzeige)
AbbVie turns a corner; patent cliff fears were overblown
AbbVie (NYSE: ABBV) is turning an important corner in 2024 and is on track to resume growth. Its Humira-related patent cliff aside, the business is stronger than ever, and the patent cliff is more
Amazon stock on the verge of a 40% rally
A 7% jump in Friday's pre-market session should tell you everything you need about Amazon.com Inc. (NASDAQ: AMZN) Q4 results. The e-commerce giant released them after the bell rang to end
Coca-Cola: Top-Rated dividend stock breaks out ahead of earnings
Shares of Coca-Cola (NYSE: KO), the Top-Rated Dividend stock, household brand name, and consumer staple giant, have staged a notable turnaround and comeback lately, with its stock rising close to
Magnificent Meta Platforms stock will double in value
Meta Platforms (NASDAQ: META) still has a long way to go to double its valuation from the pre-Q4 release market cap, but it is on track to hit a $2 trillion valuation. The company’s leaning into
2 REIT stocks set to surge due to red hot data center demand
If there’s one industry that’s set to outgrow pretty much all others in the coming years, it’s data centers. At the start of last year, McKinsey said they were expecting demand to grow by at least
Microsoft stock to $450? Here’s How
Microsoft’s (NASDAQ: MSFT) share price is driven by its growing position in the cloud. Late to the game, Microsoft has leaned hard into cloud and cloud services and AI, gaining share from Amazon
3 big banking stocks that just got upgraded
With expectations rising for the Fed to cut rates sometime this year, banking stocks are very much back in focus. While it was looking like 2023 was going to go down as one of the poorer years in
Advanced Micro Devices is at a significant turning point
Advanced Micro Devices (NASDAQ: AMD) share price imploded following the Q4 release, but investors should not fear the move. The decline is a knee-jerk reaction to expected news, setting the market
2 upgraded food stocks with super-sized gain potential
If this week ends the way it started, the U.S. stock market will head into the weekend at fresh all-time highs.
Despite light news flow, the major indices posted heavy gains on Monday before
IBM, Verizon, Merck stocks lead Dow to new highs
You don't hear as much about the Dow Jones Industrial Average as investors did a few decades ago, as the broad consensus has deemed the S&P 500 a better indicator of market conditions.
But the
IBM stock jumps to 10-year high on accelerated AI growth
International Business Machines (NYSE: IBM) stock is trading at its best levels in nearly 10 years.
Take a look at the IBM chart: The stock is up 14.42% in the past month and up 32.47% in the
4 med tech stocks with improving prognosis for 2024
Med tech stocks have been a mixed bag of results the last two years, with most moving within established trading ranges. The impact of COVID and its effect on procedure volumes were slow to
Starbucks perks up on margin strength: Are new highs in sight?
Starbucks Corporation (NASDAQ: SBUX) share prices perked up after the FQ1 release and guidance, but new highs are not in sight. The results were mixed, weak relative to the analysts' consensus
Eilt: Durchbruch in der Krebsforschung - 22% der Patienten vollständig geheilt. Neuer 250% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Durchbruch in der Krebsforschung - 22% der Patienten vollständig geheilt. Neuer 250% Biotech Hot Stock nach 31205%
31.01.24 08:02
London (www.aktiencheck.de, Anzeige)
United Parcel Service: UPS stock is going down, opportunity?
United Parcel Service (NYSE: UPS) shares fell sharply following the Q4 results and 2024 guidance, confirming resistance at a critical level. The technical signal is bearish and may shave another
Humana EPS shocker. Are Medicare Advantage plans in jeopardy?
Health insurance carrier Humana Inc. (NYSE: HUM) reported a bombshell when it released its fourth-quarter 2023 earnings report. The company not only missed its estimated EPS by a mile but also
Celsius stock finally cools off...analysts warm up to it
With temperatures well below freezing in many parts of Canada, it's only fitting that Celsius Holdings, Inc. (NASDAQ: CELH) is heading north.
Last week, the fitness energy drink maker announced
3 defense stocks that could soar on new contracts
The whole world has turned its attention to the escalating conflicts in the Red Sea involving United States and United Kingdom military personnel. While the media may underplay the significance of
Eilt: 22% der Hautkrebs-Patienten vollständig geheilt - Massives Kaufsignal. Neuer 202% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: 22% der Hautkrebs-Patienten vollständig geheilt - Massives Kaufsignal. Neuer 202% Biotech Aktientip nach 15.973%
30.01.24 08:02
London (www.aktiencheck.de , Anzeige)
Intel Q4 results: A bad sign for tech earnings
Intel's (NASDAQ: INTC) Q4 results and guidance for Q1 were mixed, to say the least, giving ample reason for the market to sell off, but the depths of the correction may have already been plumbed
Building momentum: Homebuilder sector primed for breakout
The homebuilder sector in the United States has been on fire over the previous year, mainly thanks to the Federal Reserve's growing optimism for interest rate cuts throughout 2024.
Over the